Literature DB >> 6407849

Tolerance of healthy volunteers to intravenous administration of the benzodiazepine antagonist Ro 15-1788.

A Darragh, R Lambe, M Kenny, I Brick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6407849     DOI： 10.1007/BF00609905

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788.

Authors:  A Darragh; R Lambe; M Scully; I Brick; C O'Boyle; W W Downe
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

2.  RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.

Authors:  A Darragh; R Lambe; M Kenny; I Brick; W Taaffe; C O'Boyle
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

3.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962
  3 in total
  12 in total

1.  Flumazenil reversal of conscious sedation induced with intravenous fentanyl and diazepam.

Authors:  R L Finder; P A Moore; J M Close
Journal:  Anesth Prog       Date:  1995

Review 2.  Flumazenil in dentistry.

Authors:  C Rodrigo
Journal:  Anesth Prog       Date:  1995

3.  Pharmacokinetics of the new benzodiazepine antagonist Ro 15-1788 in man following intravenous and oral administration.

Authors:  G Roncari; W H Ziegler; T W Guentert
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

Review 4.  Flumazenil: a benzodiazepine antagonist.

Authors:  J G Whitwam
Journal:  BMJ       Date:  1988-10-22

5.  Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.

Authors:  U Klotz; G Ziegler; I W Reimann
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Flumazenil does not antagonize the cardiac effects of midazolam in the isolated rat heart-lung preparation.

Authors:  T Nakamura; S Kashimoto; A Nonaka; T Kumazawa
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

7.  Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies.

Authors:  D Debruyne; P Abadie; L Barre; F Albessard; M Moulin; E Zarifian; J C Baron
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Apr-Jun       Impact factor: 2.441

8.  Reversal agents in sedation and anesthesia: a review.

Authors:  J A Anderson
Journal:  Anesth Prog       Date:  1988 Mar-Apr

9.  Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.

Authors:  N J Wesensten; T J Balkin; H Q Davis; G L Belenky
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

10.  Benzodiazepine-induced intestinal motor disturbances in rats: mediation by omega 2 (BZ2) sites on capsaicin-sensitive afferent neurones.

Authors:  C Bonnafous; B Scatton; L Buéno
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.